REPL
Replimune Group, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -1.7% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +2 | 45.55M | $503.98M | +13 | −11 |
| Q1 2026 | 75 | +4 | 41.32M | $315.89M | +10 | −6 |
| Q4 2025 | 71 | +3 | 45.45M | $441.76M | +3 | — |
| Q3 2025 | 15 | -4 | 32.26M | $135.16M | — | −4 |
| Q2 2025 | 16 | 0 | 29.86M | $277.39M | — | — |
| Q1 2025 | 13 | 0 | 20.78M | $202.64M | — | — |
| Q4 2024 | 13 | +1 | 19.63M | $237.78M | +2 | −1 |
| Q3 2024 | 11 | +1 | 14.48M | $158.71M | +1 | — |
| Q2 2024 | 10 | — | 16.01M | $144.07M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.82M | -0.3% | $100.51M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.82M | -0.3% | $100.51M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 5.73M | — | $53.24M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 3.47M | — | $32.23M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 3.47M | — | $32.23M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 3.47M | — | $32.23M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 3.47M | — | $32.23M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 3.47M | — | $32.23M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 2.45M | +2.3% | $22.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Marshall Wace ✦ | 1.87M | -25.0% | $17.34M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Marshall Wace ✦ | 1.87M | -25.0% | $17.34M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Marshall Wace ✦ | 1.87M | -25.0% | $17.34M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passief) | 1.62M | -2.9% | $15.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passief) | 1.62M | -2.9% | $15.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 944.51K | +0.9% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Wellington Management ✦ | 944.51K | +0.9% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 944.51K | +0.9% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 944.51K | +0.9% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 944.51K | +0.9% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Millennium Management ✦ | 794.05K | -35.1% | $7.38M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Point72 Asset Management ✦ | 712.54K | +642.4% | $6.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 506.60K | -36.4% | $4.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 506.60K | -36.4% | $4.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 391.66K | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 391.66K | — | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 277.47K | +1119.4% | $2.58M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Renaissance Technologies ✦ | 153.09K | -2.0% | $1.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Fisher Asset Management ✦ | 81.95K | 0.0% | $761,306 | 0.0% | Held | 5 | SEC ↗ |
| 40 | Two Sigma Investments ✦ | 22.42K | -49.5% | $208,291 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 12.21K | -7.8% | $113,450 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 12.21K | -7.8% | $113,450 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 12.21K | -7.8% | $113,450 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 70.00K aandelen, $535 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 9.26K aand · $132,176
Officer · 11.45K aand · $148,481
Officer, Director · 39.34K aand · $510,253
Officer · 7.63K aand · $98,987
Officer · 11.45K aand · $148,468
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
11.8% van klasse · Originele SEC-indiening bekijken ↗